{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:45:37Z","timestamp":1789191937053,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06650-1","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:33:30Z","timestamp":1760150010000},"page":"5055-5061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Haemoglobin variants in nigeria: real-world data from a point-of-care device"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7355-7166","authenticated-orcid":false,"given":"Taiwo","family":"Kotila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladapo","family":"Aworanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chima","family":"Akunwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ogundeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Oresanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adetunji","family":"Adewale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Alabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foluke","family":"Fasola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Olaniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"6650_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.639208","volume":"8","author":"S Shrivas","year":"2021","unstructured":"Shrivas S, Patel M, Kumar R, Gwal A, Uikey R, Tiwari SK et al (2021) Evaluation of microchip based point-of-care device gazelle for diagnosis of sickle cell disease in India. Front Med 8:639208. https:\/\/doi.org\/10.3389\/fmed.2021.639208","journal-title":"Front Med"},{"key":"6650_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4103\/ijmr.IJMR_2064_20","volume":"151","author":"I Odame","year":"2020","unstructured":"Odame I, Jain D (2020) Sickle cell disease: progress made & challenges ahead. Indian J Med Res 151:505\u2013508","journal-title":"Indian J Med Res"},{"key":"6650_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/BLT.06.036673","volume":"86","author":"B Modell","year":"2008","unstructured":"Modell B, Darlison M (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 86:480\u2013487","journal-title":"Bull World Health Organ"},{"key":"6650_CR4","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.1016\/S2352-3026(20)30143-5","volume":"7","author":"OE Nnodu","year":"2020","unstructured":"Nnodu OE, Sopekun A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G et al (2020) Implementing newborn screening for sickle cell disease as part of immunisation programmes in nigeria: a feasibility study. Lancet Haematol 7:e534\u2013e540","journal-title":"Lancet Haematol"},{"issue":"1","key":"6650_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1172-5-11","volume":"5","author":"R Galanello","year":"2010","unstructured":"Galanello R, Origa R (2010) Beta-thalassaemia. Orphanet J Rare Dis 5(1):11","journal-title":"Orphanet J Rare Dis"},{"key":"6650_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113782","volume":"9","author":"MH Steinberg","year":"2020","unstructured":"Steinberg MH (2020) Fetal hemoglobin in sickle hemoglobinopathies: High HbF genotypes and phenotypes. J Clin Med 9:3782. https:\/\/doi.org\/10.3390\/jcm9113782","journal-title":"J Clin Med"},{"issue":"10","key":"6650_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddae014","volume":"33","author":"OO Ojewunmi","year":"2024","unstructured":"Ojewunmi OO, Adeyemo TA, Oyetunji AI, Inyang B, Akinrindoye A, Mkumbe BS et al (2024) The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria. Hum Mol Genet 33(10):919\u2013929","journal-title":"Hum Mol Genet"},{"issue":"1","key":"6650_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/ajh.25305","volume":"94","author":"C Steele","year":"2019","unstructured":"Steele C, Sinski A, Asibey J, Hardy-Dessources M-D, Elana G, Brennan C et al (2019) Point-of-care screening for sickle cell disease in low-resource settings: a multi-centre evaluation of HemotypeSC, a novel rapid test. Am J Hematol 94(1):39\u201345","journal-title":"Am J Hematol"},{"issue":"1","key":"6650_CR9","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.4102\/ajlm.v11i1.1841","volume":"11","author":"C Nieuwenhuizen","year":"2022","unstructured":"Nieuwenhuizen C, Netshidzivhani T, Potgieter J (2022) Establishment of haemoglobin A2 reference intervals in Pretoria, South africa: a retrospective secondary data analysis. Afr J Lab Med 11(1):1841\u20131845","journal-title":"Afr J Lab Med"},{"key":"6650_CR10","doi-asserted-by":"crossref","unstructured":"Carrocini GCS, Ondei LS, Zamaro PJA, Bonini-Domingos CR (2011) Evaluation of HPFH and \u03b4\u03b2- thalassaemia in a Brazilian group with high HbF levels. 10(4):3213\u20133219","DOI":"10.4238\/2011.December.21.3"},{"key":"6650_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/9780470696705","volume-title":"The thalassaemia syndromes","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ, Clegg JB (2001) The \u03b2 thalassaemias. The thalassaemia syndromes, 4th edn. Blackwell Science Ltd., London","edition":"4"},{"key":"6650_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12687-021-00575-8","volume":"13","author":"GR Serjeant","year":"2022","unstructured":"Serjeant GR, Serjeant BE, Mason KP, Gibson F, Osmond C, Thein SL et al (2022) The haematology of Jamaicans: red cell indices in HbAA, HbAS, HbAC, and HbA-HPFH genotypes. J Community Genet 13:229\u2013234","journal-title":"J Community Genet"},{"issue":"2","key":"6650_CR13","first-page":"91","volume":"17","author":"OO Omotade","year":"1998","unstructured":"Omotade OO, Kayode CM, Falade SL, Ikpeme S, Adeyemo AA, Akinkugbe FM (1998) Routine screening for sickle cell haemoglobinopathy by electrophoresis in an infant welfare clinic. WAJM 17(2):91\u201394","journal-title":"WAJM"},{"key":"6650_CR14","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.3390\/jcm9113782","volume":"9","author":"MH Steinberg","year":"2020","unstructured":"Steinberg MH (2020) Fetal hemoglobin in sickle hemoglobinopathies: High HbF genotypes and phenotypes. J Clin Med 9:3782\u20133792","journal-title":"J Clin Med"},{"issue":"6","key":"6650_CR15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/pbc.25936","volume":"63","author":"MP Smeltzer","year":"2016","unstructured":"Smeltzer MP, Nolan VG, Yu X, Nottage KA, Davis BA, Yang Y et al (2016) Birth prevalence of sickle cell trait and sickle cell disease in Shelby County, TN. Pediatr Blood Cancer 63(6):1054\u20131059","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"6650_CR16","first-page":"46","volume":"9","author":"TR Kotila","year":"2009","unstructured":"Kotila TR, Adeyemo AA, Mewoyeka OO, Shokunbi WA (2009) Beta thalassaemia trait in Western Nigeria. Afr Health Sci 9(1):46\u201349","journal-title":"Afr Health Sci"},{"key":"6650_CR17","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2014.18.71.4239","volume":"18","author":"T Adeyemo","year":"2014","unstructured":"Adeyemo T, Ojewunmi O, Oyetunji A (2014) Evaluation of high-performance liquid chromatography (HPLC) pattern and prevalence of beta thalassaemia trait among sickle cell disease patients in Lagos, Nigeria. Pan Afr Med J 18:71. https:\/\/doi.org\/10.11604\/pamj.2014.18.71.4239","journal-title":"Pan Afr Med J"},{"key":"6650_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/atp.atp_45_17","volume":"9","author":"A Akinbami","year":"2018","unstructured":"Akinbami A, Uche E, Dosunmu A et al (2018) Haemoglobin F and A2 profiles among sickle cell anaemia patients in Lagos state university teaching hospital (LASUTH), Nigeria. Ann Trop Pathol 9:26\u201331","journal-title":"Ann Trop Pathol"},{"issue":"1","key":"6650_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.18502\/sjms.v16i1.8935","volume":"16","author":"IA Durotoye","year":"2021","unstructured":"Durotoye IA, Salaudeen AG, Sanni EO, Babatunde AS, Durowade AK, Olawumi HO et al (2021) Determination of normal and variant hemoglobin using capillary electrophoresis among voluntary blood donors in North central Nigeria: implications on blood transfusion services. Sudan J Med Sci 16(1):33\u201342","journal-title":"Sudan J Med Sci"},{"issue":"9","key":"6650_CR20","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3324\/haematol.12840","volume":"93","author":"A Giambona","year":"2008","unstructured":"Giambona A, Passarello C, Vinciguerra M, Li Muli R, Teresi P, Anz\u00e0 M et al (2008) Significance of borderline hemoglobin A2 values in an Italian population with high prevalence of beta thalassaemia. Haematologica 93(9):1380\u20131384","journal-title":"Haematologica"},{"key":"6650_CR21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1017\/CBO9780511596582.031","volume-title":"Disorders of haemoglobins: Genetics, pathophysiology and clinical management","author":"MH Steinberg","year":"2009","unstructured":"Steinberg MH (2009) Other sickle hemoglobinopathies. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ (eds) Disorders of haemoglobins: Genetics, pathophysiology and clinical management, 2nd edn. Cambridge University Press, New York, pp 564\u2013586","edition":"2"},{"key":"6650_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMra2021838","volume":"384","author":"AT Taher","year":"2021","unstructured":"Taher AT, Musallam KM, Cappellini MD (2021) \u03b2 thalassaemias. N Engl J Med 384:727\u2013743","journal-title":"N Engl J Med"},{"key":"6650_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jha2.186","volume":"2","author":"TA Adeyemo","year":"2021","unstructured":"Adeyemo TA, Ojewunmi OO, Oyetunji IA, Kalejaiye OO, Menzel S (2021) Fetal haemoglobin enhancing genotype at BCL11A reduces HbA2 levels in patients with sickle cell anaemia. EJhaem 2:459\u2013461","journal-title":"EJhaem"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06650-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06650-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06650-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:02:51Z","timestamp":1763420571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06650-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["6650"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06650-1","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}